Tejara Capital’s TherapeuticsMD TXMD Stock Holding History

Tejara Capital’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$699K	Sell	345,852 -5,000	-1%	-$11.2K	0.23%	67
2025 Q4	$572K	Buy	350,852 +6,649	+2%	+$9.61K	0.13%	57
2025 Q3	$370K	Sell	344,203 -51	-0%	-$57	0.19%	44
2025 Q2	$399K	Sell	344,254 -341	-0.1%	-$413	0.19%	68
2025 Q1	$319K	Sell	344,595 -50,066	-13%	-$49.9K	0.12%	73
2024 Q4	$339K	Sell	394,661 -6,785	-2%	-$9.55K	0.22%	50
2024 Q3	$666K	Sell	401,446 -491	-0.1%	-$855	0.32%	48
2024 Q2	$647K	Hold	401,937	–	–	0.24%	55
2024 Q1	$920K	Hold	401,937	–	–	0.34%	52
2023 Q4	$904K	Buy	401,937 +32,343	+9%	+$78K	0.38%	48
2023 Q3	$1.12M	Hold	369,594	–	–	0.63%	38
2023 Q2	$1.52M	Buy	369,594 +13,915	+4%	+$54.6K	0.75%	35
2023 Q1	$1.33M	Buy	355,679 +38,366	+12%	+$184K	0.68%	39
2022 Q4	$1.77M	Buy	+317,313	New	+$1.87M	1.02%	28

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $273M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Tejara Capital's TXMD Position: Q1 2026 in Review

Tejara Capital reduced its TherapeuticsMD (TXMD) stake by 1.4% in Q1 2026, selling an estimated $11.2K and leaving 345,852 shares worth $699K. The position accounts for 0.23% of the portfolio, ranked #67.

Tejara Capital first reported a position in TXMD in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.77M in Q4 2022. 49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

Tejara Capital held 345,852 shares of TherapeuticsMD worth $699K as of Q1 2026.
Tejara Capital sold 5,000 TherapeuticsMD shares in Q1 2026, an estimated $11.2K.
TherapeuticsMD made up 0.23% of Tejara Capital's portfolio in Q1 2026, its #67 holding.
Tejara Capital first reported a position in TherapeuticsMD in Q4 2022 and has held it in 14 quarters since.
Tejara Capital's TherapeuticsMD position peaked at $1.77M in Q4 2022.
49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on Tejara Capital's 13F filing for Q1 2026, filed 12 May 2026.